Cardiff Lexington Corp financial data

Symbol
CDIX on OTC
Industry
Services-Offices & Clinics of Doctors of Medicine
Location
3753 Howard Hughes Parkway, Suite 200, Las Vegas, NV
State of incorporation
FL
Fiscal year end
December 31
Former names
CARDIFF INTERNATIONAL INC (to 1/26/2018)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 113 % +36.9%
Debt-to-equity 508 %
Return On Equity -74.3 % -202%
Return On Assets -9.37 % -92%
Operating Margin -1.47 % -103%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15M shares -98.9%
Common Stock, Shares, Outstanding 14.6M shares -98.7%
Entity Public Float 869K USD
Common Stock, Value, Issued 14.6K USD -98.7%
Weighted Average Number of Shares Outstanding, Basic 14.1M shares
Weighted Average Number of Shares Outstanding, Diluted 14.1M shares +1671%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 7.53M USD -30.7%
Cost of Revenue 3.71M USD +12.5%
Operating Income (Loss) -111K USD -102%
Nonoperating Income (Expense) -1.93M USD +45.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.04M USD -212%
Net Income (Loss) Attributable to Parent -2.15M USD -183%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 14.8M USD +24.9%
Assets, Current 16.8M USD +39.2%
Property, Plant and Equipment, Net 24.6K USD -44.3%
Operating Lease, Right-of-Use Asset 465K USD +131%
Goodwill 5.67M USD 0%
Assets 23.5M USD +27%
Accounts Payable, Current 663K USD -16.8%
Liabilities, Current 14.6M USD +23.1%
Operating Lease, Liability, Noncurrent 237K USD +269%
Liabilities 15M USD +24.1%
Retained Earnings (Accumulated Deficit) -71.8M USD -4.53%
Stockholders' Equity Attributable to Parent 3.73M USD +452%
Liabilities and Equity 23.5M USD +27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Financing Activities 313K USD +4.24%
Common Stock, Shares Authorized 300M shares -96%
Common Stock, Shares, Issued 14.6M shares -98.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.95M USD +976%
Interest Paid, Excluding Capitalized Interest, Operating Activities 50K USD +3227%
Deferred Tax Assets, Valuation Allowance 5.29M USD -11.7%
Deferred Tax Assets, Gross 5.29M USD -11.7%
Operating Lease, Liability 464K USD
Depreciation 19.5K USD +849%
Lessee, Operating Lease, Liability, to be Paid 464K USD +132%
Property, Plant and Equipment, Gross 137K USD -10.3%
Operating Lease, Liability, Current 228K USD +67.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 77.9K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 172K USD +167%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 36.1K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.61K USD
Preferred Stock, Shares Authorized 50M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.55K USD -71%
Additional Paid in Capital 20.9M USD
Depreciation, Depletion and Amortization 3.37K USD -27.4%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 195K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares